Federal Register : Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
09 Jan 2026
Source: Federal Register
AGENCY:
Drug Enforcement Administration, Department of Justice; Substance Abuse and Mental Health Services Administration, Department of Health and Human Services.
ACTION:
Temporary rule.
SUMMARY:
The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.
DATES:
This rule is effective January 1, 2026 through December 31, 2026.